TEQWX
Price
$40.23
Change
-$0.10 (-0.25%)
Updated
Sep 20 closing price
VFIAX
Price
$527.71
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

TEQWX vs VFIAX

Header iconTEQWX vs VFIAX Comparison
Open Charts TEQWX vs VFIAXBanner chart's image
Nuveen Equity Index W
Price$40.23
Change-$0.10 (-0.25%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$527.71
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TEQWX vs VFIAX Comparison Chart
Loading...
VS
TEQWX vs. VFIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQWX is a Buy and VFIAX is a Buy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.24T vs. TEQWX (48B). TEQWX (1.37) and VFIAX (1.32) have matching dividends . TEQWX was incepted earlier than VFIAX: TEQWX (6 years) vs VFIAX (24 years). TEQWX is a more actively managed with annual turnover of: 7.00 vs. VFIAX (2.00). TEQWX has a lower initial minimum investment than VFIAX: TEQWX (0) vs VFIAX (3000). TEQWX (27.63) and VFIAX (26.45) have marching annual gain over last year. TEQWX (91.89) and VFIAX (87.65) have equivalent 5 years return.
TEQWXVFIAXTEQWX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD17.69618.19097%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets48B1.24T4%
Annual Yield % from dividends1.371.32104%
Returns for 1 year27.6326.45104%
Returns for 3 years24.1426.7690%
Returns for 5 years91.8987.65105%
Returns for 10 yearsN/A182.25-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CENT38.330.56
+1.48%
Central Garden & Pet Company
HFWA22.070.07
+0.32%
Heritage Financial Corp
SAMG16.64-0.03
-0.18%
Silvercrest Asset Management Group
JKHY174.21-1.48
-0.84%
Jack Henry & Associates
COEP0.18N/A
-2.50%
Coeptis Therapeutics Holdings